Personalis, Inc. Capital Expenditures
Personalis, Inc. (PSNL) reported Capital Expenditures of $6.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-04
- Personalis, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $3.78M, a 1204.14% increase year-over-year.
- Personalis, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $3.19M, a 27.12% increase year-over-year.
- Personalis, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $77.00K, a 93.82% decline year-over-year.
- Personalis, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $1.63M, a 558.30% increase year-over-year.
- Personalis, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $4.50M, a 180.97% increase from fiscal 2024.
- Personalis, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $1.60M, a 85.31% decline from fiscal 2023.
- Personalis, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $10.91M, a 78.13% decline from fiscal 2022.
- Personalis, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $49.90M, a 350.20% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $6.97M 10-Q · filed 2026-08-04 | $7.05M derived: sum of 3 quarters · filed 2026-08-04 | $8.68M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $3.19M 10-Q · filed 2026-05-07 | $3.27M derived: sum of 2 quarters · filed 2026-05-07 | $4.89M derived: sum of 3 quarters · filed 2026-05-07 | $5.18M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.70M derived: sum of 2 quarters · filed 2026-02-26 | $1.99M derived: sum of 3 quarters · filed 2026-08-04 | $4.50M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.92M derived: sum of 2 quarters · filed 2026-08-04 | $4.43M 10-Q · filed 2025-11-04 | $5.67M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $290.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.80M 10-Q · filed 2026-08-04 | $4.05M derived: sum of 3 quarters · filed 2026-08-04 | $4.29M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $2.51M 10-Q · filed 2026-05-07 | $3.76M derived: sum of 2 quarters · filed 2026-05-07 | $4.00M derived: sum of 3 quarters · filed 2026-05-07 | $4.01M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.49M derived: sum of 2 quarters · filed 2026-02-26 | $1.50M derived: sum of 3 quarters · filed 2026-02-26 | $1.60M 10-K · filed 2026-02-26 |
| 2024-09-30 | $247.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $253.00K derived: sum of 2 quarters · filed 2025-11-04 | $357.00K 10-Q · filed 2025-11-04 | $3.88M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $110.00K 10-Q · filed 2025-08-05 | $3.63M derived: sum of 3 quarters · filed 2025-08-05 | $4.50M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $104.00K 10-Q · filed 2025-05-06 | $3.63M derived: sum of 2 quarters · filed 2025-05-06 | $4.50M derived: sum of 3 quarters · filed 2025-05-06 | $7.24M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $4.39M derived: sum of 2 quarters · filed 2025-02-27 | $7.13M derived: sum of 3 quarters · filed 2025-02-27 | $10.91M 10-K · filed 2025-02-27 |
| 2023-09-30 | $868.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $3.61M derived: sum of 2 quarters · filed 2024-11-06 | $7.39M 10-Q · filed 2024-11-06 | $16.93M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $2.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $6.52M 10-Q · filed 2024-08-07 | $16.06M derived: sum of 3 quarters · filed 2024-08-07 | $37.47M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $3.78M 10-Q · filed 2024-05-08 | $13.32M derived: sum of 2 quarters · filed 2024-05-08 | $34.73M derived: sum of 3 quarters · filed 2024-05-08 | $45.04M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $9.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $30.95M derived: sum of 2 quarters · filed 2024-02-28 | $41.26M derived: sum of 3 quarters · filed 2024-02-28 | $49.90M 10-K · filed 2024-02-28 |
| 2022-09-30 | $21.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $31.72M derived: sum of 2 quarters · filed 2023-11-07 | $40.36M 10-Q · filed 2023-11-07 | $43.94M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $10.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $18.94M 10-Q · filed 2023-08-08 | $22.52M derived: sum of 3 quarters · filed 2024-02-28 | $25.48M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $8.63M 10-Q · filed 2023-05-03 | $12.21M derived: sum of 2 quarters · filed 2024-02-28 | $15.17M derived: sum of 3 quarters · filed 2024-02-28 | $19.28M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $3.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $6.54M derived: sum of 2 quarters · filed 2024-02-28 | $10.64M derived: sum of 3 quarters · filed 2024-02-28 | $11.08M 10-K · filed 2024-02-28 |
| 2021-09-30 | $2.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $7.07M derived: sum of 2 quarters · filed 2022-11-02 | $7.51M 10-Q · filed 2022-11-02 | $8.34M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $4.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $4.54M 10-Q · filed 2022-08-03 | $5.38M derived: sum of 3 quarters · filed 2023-02-23 | $6.93M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $439.00K 10-Q · filed 2022-05-04 | $1.28M derived: sum of 2 quarters · filed 2023-02-23 | $2.83M derived: sum of 3 quarters · filed 2023-02-23 | $3.61M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $837.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.39M derived: sum of 2 quarters · filed 2023-02-23 | $3.17M derived: sum of 3 quarters · filed 2023-02-23 | $3.25M 10-K · filed 2023-02-23 |
| 2020-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.33M derived: sum of 2 quarters · filed 2021-11-04 | $2.41M 10-Q · filed 2021-11-04 | $4.32M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $779.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $855.00K 10-Q · filed 2021-08-04 | $2.77M derived: sum of 3 quarters · filed 2022-02-24 | $6.44M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $76.00K 10-Q · filed 2021-05-05 | $1.99M derived: sum of 2 quarters · filed 2022-02-24 | $5.66M derived: sum of 3 quarters · filed 2022-02-24 | $7.50M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $5.58M derived: sum of 2 quarters · filed 2022-02-24 | $7.42M derived: sum of 3 quarters · filed 2022-02-24 | $8.38M 10-K · filed 2022-02-24 |
| 2019-09-30 | $3.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $5.51M derived: sum of 2 quarters · filed 2020-11-05 | $6.47M 10-Q · filed 2020-11-05 | $7.14M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $1.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $2.80M 10-Q · filed 2020-08-06 | $3.47M derived: sum of 3 quarters · filed 2021-02-25 | $5.42M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $960.00K 10-Q · filed 2020-05-07 | $1.63M derived: sum of 2 quarters · filed 2021-02-25 | $3.58M derived: sum of 3 quarters · filed 2021-02-25 | |
| 2018-12-31 | $671.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.62M derived: sum of 2 quarters · filed 2021-02-25 | $7.85M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $7.18M 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $5.24M 10-Q · filed 2019-08-13 | |||
| 2017-12-31 | $5.16M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |